Search Results
Feb 27, 2026, 02:53 ET CORT Investors Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit with the Schall Law Firm
CORT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange
More news about: The Schall Law Firm
Feb 26, 2026, 15:17 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Corcept Therapeutics Incorporated of Class Action Lawsuit and Upcoming Deadlines - CORT
Pomerantz LLP announces that a class action lawsuit has been filed against Corcept Therapeutics Incorporated ("Corcept" or the "Company") (NASDAQ: CORT). Such investors are advised to contact Danielle Peyton at [email protected] or
More news about: Pomerantz LLP
Feb 26, 2026, 11:56 ET Corcept Therapeutics (CORT) Litigation: Hagens Berman Alerts Corcept (CORT) Investors to Securities Class Action and April 21 Lead Plaintiff Deadline
Corcept Therapeutics Inc. (NASDAQ: CORT) and certain of its top executives. The lawsuit, Allegheny County Employees' Retirement System v. Corcept Therapeutics Incorporated, No. 26-cv-01525 (N.D. Cal.), seeks to recover losses for investors who purchased CORT common stock between October 31,
More news about: Hagens Berman Sobol Shapiro LLP
Feb 24, 2026, 17:09 ET CORT Stockholder Notice: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against Corcept Therapeutics Inc.
stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Corcept Therapeutics Incorporation (NASDAQ: CORT) common stock between October 31, 2024 and December 30, 2025. Corcept is a pharmaceutical company focused on the development of medications to treat
More news about: Robbins LLP
Feb 24, 2026, 08:34 ET Corcept Therapeutics (CORT) Litigation: Hagens Berman Alerts Corcept (CORT) Investors to Securities Class Action and April 21 Lead Plaintiff Deadline
Corcept Therapeutics Inc. (NASDAQ: CORT) and certain of its top executives. The lawsuit, Allegheny County Employees' Retirement System v. Corcept Therapeutics Incorporated, No. 26-cv-01525 (N.D. Cal.), seeks to recover losses for investors who purchased CORT common stock between October 31,
More news about: Hagens Berman Sobol Shapiro LLP
Feb 23, 2026, 19:25 ET CORT Investors Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit
global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Corcept Therapeutics Incorporated (NASDAQ: CORT) between October 31, 2024 and December 30, 2025, inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve
More news about: THE ROSEN LAW FIRM, P. A.
Feb 23, 2026, 09:12 ET INVESTOR DEADLINE: Corcept Therapeutics Incorporated Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
LLP announces that the Corcept class action lawsuit seeks to represent purchasers or acquirers of Corcept Therapeutics Incorporated (NASDAQ: CORT) common stock between October 31, 2024 and December 30, 2025, inclusive (the "Class Period"). Captioned Allegheny County Employees' Retirement System
More news about: Robbins Geller Rudman & Dowd LLP
Feb 23, 2026, 09:00 ET Ubicquia Secures $106 Million in Series D Funding to Accelerate Intelligent Infrastructure Growth
are thrilled to lead this round and support Ubicquia's transformative vision for leveraging AI to monitor and digitize critical infrastructure," said Cort Ahl, Partner at 67 Capital. "Ubicquia stands out for its ability to turn existing urban and utility infrastructure into AI-enabled networks that deliver
More news about: Ubicquia, Inc.
Feb 23, 2026, 09:00 ET Ubicquia Secures $106 Million in Series D Funding to Accelerate Intelligent Infrastructure Growth
are thrilled to lead this round and support Ubicquia's transformative vision for leveraging AI to monitor and digitize critical infrastructure," said Cort Ahl, Partner at 67 Capital. "Ubicquia stands out for its ability to turn existing urban and utility infrastructure into AI-enabled networks that deliver
More news about: Ubicquia, Inc.
Feb 23, 2026, 09:00 ET Ubicquia sichert sich 106 Millionen US-Dollar in einer Series-D-Finanzierungsrunde, um das Wachstum intelligenter Infrastrukturen zu beschleunigen
die transformative Vision von Ubicquia für die Nutzung von KI zur Überwachung und Digitalisierung kritischer Infrastrukturen zu unterstützen", sagte Cort Ahl, Partner bei 67 Capital. „Ubicquia zeichnet sich durch seine Fähigkeit aus, bestehende städtische Infrastrukturen und Versorgungsnetze in KI-fähige
More news about: Ubicquia, Inc.
Feb 23, 2026, 09:00 ET Ubicquia capta US$ 106 milhões em rodada Série D para acelerar expansão de infraestrutura inteligente
rodada e apoiar a visão transformadora da Ubicquia de utilizar inteligência artificial para monitorar e digitalizar infraestruturas críticas", afirmou Cort Ahl, sócio da 67 Capital. "A Ubicquia se destaca por sua capacidade de transformar a infraestrutura urbana e de serviços públicos já existente em redes
More news about: Ubicquia, Inc.
Feb 23, 2026, 09:00 ET Ubicquia obtiene 106 millones de dólares en financiación para infraestructura inteligente
liderar esta ronda y apoyar la visión transformadora de Ubicquia para aprovechar la IA para monitorizar y digitalizar infraestructuras críticas", explicó Cort Ahl, socio de 67 Capital. "Ubicquia destaca por su capacidad para convertir la infraestructura urbana y de servicios públicos existente en redes basadas
More news about: Ubicquia, Inc.
Feb 23, 2026, 09:00 ET Ubicquia obtiene 106 millones en fondos de la Serie D para acelerar el crecimiento de la infraestructura inteligente
liderar esta ronda y apoyar la visión transformadora de Ubicquia para aprovechar la IA para monitorear y digitalizar la infraestructura crítica", comentó Cort Ahl, socio de 67 Capital. "Ubicquia se destaca por su capacidad para convertir la infraestructura urbana y de servicios públicos existente en redes
More news about: Ubicquia, Inc.
Feb 23, 2026, 09:00 ET Ubicquia obtient un financement de série D de 106 millions de dollars pour accélérer la croissance des infrastructures intelligentes
soutenir la vision transformatrice d'Ubicquia, qui consiste à tirer parti de l'IA pour surveiller et numériser les infrastructures critiques », a déclaré Cort Ahl, associé chez 67 Capital. « Ubicquia se distingue par sa capacité à transformer les infrastructures urbaines et de services publics existantes en
More news about: Ubicquia, Inc.
Feb 12, 2026, 18:56 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Incorporated - CORT
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Corcept Therapeutics Incorporated ("Corcept" or the "Company") (NASDAQ: CORT). Such investors are advised to contact Danielle Peyton at [email protected] or
More news about: Pomerantz LLP
Feb 09, 2026, 08:12 ET CORT INVESTIGATION ALERT: Investigation Launched into Corcept Therapeutics (CORT), Hagens Berman Encourages Investors to Contact Firm
www.hbsslaw.com/investor-fraud/cortContact the Firm Now: [email protected] 844-916-0895Corcept Therapeutics (CORT) Investigation:
More news about: Hagens Berman Sobol Shapiro LLP
Feb 09, 2026, 04:54 ET Corcept Therapeutics Incorporated Investigated on Behalf of Investors - Contact the DJS Law Group to Discuss Your Rights - CORT
CORT) for violations of the securities laws. INVESTIGATION DETAILS: The investigation focuses on whether the Company issued misleading statements
More news about: DJS Law Group LLP
Feb 09, 2026, 03:38 ET CORT Investors Have Opportunity to Join Corcept Therapeutics Incorporated Fraud Investigation with the Schall Law Firm
CORT) for violations of the securities laws.
More news about: The Schall Law Firm
Feb 05, 2026, 05:21 ET CORT Investors Have Opportunity to Join Corcept Therapeutics Incorporated Fraud Investigation with the Schall Law Firm
CORT) for violations of the securities laws.
More news about: The Schall Law Firm
Feb 05, 2026, 04:48 ET Corcept Therapeutics Incorporated Investigated on Behalf of Investors - Contact the DJS Law Group to Discuss Your Rights - CORT
CORT) for violations of the securities laws. INVESTIGATION DETAILS: The investigation focuses on whether the Company issued misleading statements
More news about: DJS Law Group LLP
Feb 02, 2026, 17:46 ET CORT INVESTIGATION ALERT: Investigation Launched into Corcept Therapeutics (CORT), Hagens Berman Encourages Investors to Contact Firm
www.hbsslaw.com/investor-fraud/cortContact the Firm Now: [email protected] 844-916-0895Corcept Therapeutics (CORT) Investigation:
More news about: Hagens Berman Sobol Shapiro LLP
Feb 02, 2026, 04:42 ET Corcept Therapeutics Incorporated Investigated on Behalf of Investors - Contact the DJS Law Group to Discuss Your Rights - CORT
CORT) for violations of the securities laws. INVESTIGATION DETAILS: The investigation focuses on whether the Company issued misleading statements
More news about: DJS Law Group LLP
Feb 02, 2026, 04:41 ET CORT Investors Have Opportunity to Join Corcept Therapeutics Incorporated Fraud Investigation with the Schall Law Firm
CORT) for violations of the securities laws.
More news about: The Schall Law Firm
Jan 29, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Incorporated - CORT
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Corcept Therapeutics Incorporated ("Corcept" or the "Company") (NASDAQ: CORT). Such investors are advised to contact Danielle Peyton at [email protected] or
More news about: Pomerantz LLP
Jan 29, 2026, 04:30 ET CORT Investors Have Opportunity to Join Corcept Therapeutics Incorporated Fraud Investigation with the Schall Law Firm
CORT) for violations of the securities laws.
More news about: The Schall Law Firm